| Original language | Undefined/Unknown |
|---|---|
| Article number | e18 |
| Journal | Neurology neuroimmunology & neuroinflammation |
| Volume | 1 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2014 |
Cite this
}
Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033. / Tran, J.Q.; Rana, J.; Barkhof, F.; Melamed, I.; Gevorkyan, H.; Wattjes, M.P.; Jong, R.; Brosofsky, K.; Ray, S.; Xu, L.; Zhao, J.; Parr, E.; Cadavid, D.
In: Neurology neuroimmunology & neuroinflammation, Vol. 1, No. 2, e18, 2014.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033
AU - Tran, J.Q.
AU - Rana, J.
AU - Barkhof, F.
AU - Melamed, I.
AU - Gevorkyan, H.
AU - Wattjes, M.P.
AU - Jong, R.
AU - Brosofsky, K.
AU - Ray, S.
AU - Xu, L.
AU - Zhao, J.
AU - Parr, E.
AU - Cadavid, D.
PY - 2014
Y1 - 2014
U2 - 10.1212/NXI.0000000000000018
DO - 10.1212/NXI.0000000000000018
M3 - Article
VL - 1
JO - Neurology neuroimmunology & neuroinflammation
JF - Neurology neuroimmunology & neuroinflammation
SN - 2332-7812
IS - 2
M1 - e18
ER -